#aad? ,,congress #b;d ,session ,h4 ,r4 #digf ,,an ,,act ,to require ! ,commission] ( ,food & ,drugs to seek recomm5dations f an advisory committee ( ! ,food & ,drug ,adm9i/ration be=e approval ( c]ta9 new drugs t are opioids )\t abuse-det]r5t prop]ties1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,opioid ,review ,mod]nization ,act ( #bjaf4 #b4 ,,fda opioid action plan ,*apt] ,v ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act is am5d$ by ins]t+ aft] section #efi ( su* ,act 7#ba ,u4,s4,c4 #cej;bbb-#h7 ! foll[+3 #efi-a4 ,opioid action plan 7a7 ,new drug application 7#a7 ,9 g5]al ,subject to p>agraph 7#b71 prior to ! approval pursuant to an application "u section #eje7;b7 ( a new drug t is an opioid & does n h abuse-det]r5t prop]ties1 ! ,secret>y %all ref] ! application to an advisory committee ( ! ,food & ,drug ,adm9i/ration to seek recomm5dations f su* advisory committee4 7#b7 ,public heal? exemption ,a ref]ral to an advisory committee "u p>agraph 7#a7 is n requir$ ) respect to a new drug if ! ,secret>y-- 7,a7 f9ds t su* a ref]ral is n 9 ! int]e/ ( protect+ & promot+ public heal?2 7,b7 f9ds t su* a ref]ral is n necess>y bas$ on a review ( ! relevant sci5tific in=mation2 & 7,c7 submits a notice conta9+ ! rationale = su* f9d+s to ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ( ! ,s5ate & ! ,committee on ,en]gy & ,comm]ce ( ! ,h\se ( ,repres5tatives4 7b7 ,p$iatric opioid label+ ,! ,secret>y %all conv5e ! ,p$iatric ,advisory ,committee ( ! ,food & ,drug ,adm9i/ration to seek recomm5dations f su* ,committee reg>d+ a framework = ! inclusion ( in=mation 9 ! label+ ( drugs t are opioids relat+ to ! use ( su* drugs 9 p$iatric populations be=e ! ,secret>y approves any label+ or *ange to label+ = any drug t is an opioid int5d$ = use 9 a p$iatric population4 7c7 ,sunset ,! requirem5ts ( subsections 7a7 & 7b7 %all cease to be effective on ,octob] #a1 #bjbb4 4 #c4 ,prescrib] education ,n lat] ?an #a ye> aft] ! date ( ! enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices1 act+ ?r\gh ! ,commission] ( ,food & ,drugs1 z "p ( ! ,food & ,drug ,adm9i/ration's evaluation ( ! ,ext5d$-,release_/,long-,act+ ,opioid ,analgesics ,risk ,evaluation & ,mitigation ,/rategy1 & 9 consultation ) relevant /akehold]s1 %all develop recomm5dations reg>d+ education programs = prescrib]s ( opioids pursuant to section #eje-a ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee-a71 includ+ recomm5dations on-- 7#a7 :i* prescrib]s %\ld p>ticipate 9 su* programs2 & 7#b7 h[ (t5 p>ticipation 9 su* programs is necess>y4 #d4 ,guidance on evaluat+ ! abuse det]r5ce ( g5]ic solid oral opioid drug products ,n lat] ?an #b ye>s aft] ! end ( ! p]iod = public comm5t on ! draft guidance entitl$ ,g5]al ,pr9cipals = ,evaluat+ ! ,abuse ,det]r5ce ( ,g5]ic ,solid ,oral ,opioid ,drug ,products issu$ by ! ,c5t] = ,drug ,evaluation & ,rese>* ( ! ,food & ,drug ,adm9i/ration 9 ,m>* #bjaf1 ! ,commission] ( ,food & ,drugs %all publi% 9 ! ,f$]al ,regi/] a f9al v]sion ( su* guidance4 ,pass$ ! ,h\se ( ,repres5tatives ,may #aa1 #bjaf4;,cl]k4